Furiex Pharmaceuticals (FURX) is a drug development collaboration company. Furiex's product pipeline includes two marketed products and three programs in development, including late-stage compounds, in multiple therapeutic areas. This stock is trading up 2.9% at $20.39 in recent trading.
Today's Volume: 149,000Average Volume: 85,138 Volume % Change: 84% Shares of FURX are ripping higher today ahead of the company's earnings report, which is set for Thursday after the market close. From a technical perspective, FURX has started to move back above its 50-day moving average of $19.83 here with above average volume. >>5 Biotech Stocks Poised for Breakouts Traders should continue to look for long-biased trades in FURX ahead of its earnings report as long as it's trading above $19.83 with strong volume. I would consider any upside volume day that registers near or above 85,138 shares as bullish. After earnings, I would look for long-biased trades in FURX if it can manage to trigger a major breakout trade. That trade will hit once FURX takes out some near-term overheard resistance at $22.47 with high volume. Look for a sustained move or close above $22.47 or Thursday's high (if it's greater) with volume that's near or above 85,138 shares. If we get that action, then look for FURX to hit $25 or higher post-earnings.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV